Evidence map›Paper›PMID 26854933›Full record

ArticleExperimental neurology2016

Reducing synuclein accumulation improves neuronal survival after spinal cord injury.

Stephanie M Fogerson, Alexandra J van Brummen, David J Busch, Scott R Allen, Robin Roychaudhuri, Susan M L Banks, Frank-Gerrit Klärner, Thomas Schrader, Gal Bitan, Jennifer R Morgan

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Stephanie M FogersonMarine Biological Laboratory, The Eugene Bell Center for Regenerative Biology and Tissue Engineering, Woods Hole, MA 02543, United States.
Alexandra J van BrummenMarine Biological Laboratory, The Eugene Bell Center for Regenerative Biology and Tissue Engineering, Woods Hole, MA 02543, United States; Section of Molecular Cell and Developmental Biology, The University of Texas at Austin, Austin, TX 78712, United States.
David J BuschSection of Molecular Cell and Developmental Biology, The University of Texas at Austin, Austin, TX 78712, United States.
Scott R AllenMarine Biological Laboratory, The Eugene Bell Center for Regenerative Biology and Tissue Engineering, Woods Hole, MA 02543, United States.
Robin RoychaudhuriDepartment of Neurology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, United States.
Susan M L BanksMarine Biological Laboratory, The Eugene Bell Center for Regenerative Biology and Tissue Engineering, Woods Hole, MA 02543, United States.
Frank-Gerrit KlärnerInstitute of Organic Chemistry, University of Duisburg-Essen, Essen 45117, Germany.
Thomas SchraderInstitute of Organic Chemistry, University of Duisburg-Essen, Essen 45117, Germany.
Gal BitanDepartment of Neurology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, United States; Brain Research Institute and Molecular Biology Institute, University of California at Los Angeles, Los Angeles, CA 90095, United States.
Jennifer R MorganMarine Biological Laboratory, The Eugene Bell Center for Regenerative Biology and Tissue Engineering, Woods Hole, MA 02543, United States. Electronic address: jmorgan@mbl.edu.
Marine Biological Laboratory · USUniversity of California, Los Angeles · USUniversity of Duisburg-Essen · DEThe University of Texas at Austin · US

Funding

ORGANIZATION AND FUNCTIONS OF CELLULAR STRUCTUREST32GM007184 · NIGMS · DUKE UNIVERSITY · PI JINKS-ROBERTSON, SUE · 1985 to 2019
$18.2M
Mechanisms of Synaptic Dysfunction in Parkinson s and Other Synuclein-Linked DiseasesR01NS078165 · NINDS · UNIVERSITY OF TEXAS AT AUSTIN · PI Jennifer Rebecca Morgan · 2012 to 2026
$5.5M
NIGMS NIH HHS T32 GM007184NINDS NIH HHS R01 NS078165
6 · The paper itself

Abstract

Spinal cord injury causes neuronal death, limiting subsequent regeneration and recovery. Thus, there is a need to develop strategies for improving neuronal survival after injury. Relative to our understanding of axon regeneration, comparatively little is known about the mechanisms that promote the survival of damaged neurons. To address this, we took advantage of lamprey giant reticulospinal neurons whose large size permits detailed examination of post-injury molecular responses at the level of individual, identified cells. We report here that spinal cord injury caused a select subset of giant reticulospinal neurons to accumulate synuclein, a synaptic vesicle-associated protein best known for its atypical aggregation and causal role in neurodegeneration in Parkinson's and other diseases. Post-injury synuclein accumulation took the form of punctate aggregates throughout the somata and occurred selectively in dying neurons, but not in those that survived. In contrast, another synaptic vesicle protein, synaptotagmin, did not accumulate in response to injury. We further show that the post-injury synuclein accumulation was greatly attenuated after single dose application of either the "molecular tweezer" inhibitor, CLR01, or a translation-blocking synuclein morpholino. Consequently, reduction of synuclein accumulation not only improved neuronal survival, but also increased the number of axons in the spinal cord proximal and distal to the lesion. This study is the first to reveal that reducing synuclein accumulation is a novel strategy for improving neuronal survival after spinal cord injury.

Indexed as

Analysis of VarianceAnimalsBridged-Ring CompoundsCell CountDisease Models, AnimalGene Expression RegulationLampreysLarvaMorpholinosNeuronsOrganophosphatesSpinal Cord InjuriesSynucleinsBridged-Ring CompoundsCLR01 compoundMorpholinosOrganophosphatesSynucleinsCLR01LampreyMolecular tweezerNeurodegenerationParkinson's diseaseSynaptotagmin

Identifiers

PMID26854933
PMCPMC4788542
OpenAlexW2258388403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.